Printer Friendly

Teijin Pharma Releases SAS Testing Device.

Tokyo, Japan, Aug 21, 2006 - (JCN) - Teijin Pharma released the SAS-2100, a device to test and screen sleep apnea syndrome (SAS) at home, on August 21. Used with a wristband weighing only 100g, the device can detect whether or not there is apnea, and if any, its intensity, without technical, all-night testing of electroencephalogram at hospital.

With the device, a suspected SAS patient can record his/her respiratory conditions while sleeping, and medical institutions can download those data to PCs for analysis using dedicated software. The price is set at 775,000 yen.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Aug 22, 2006
Words:103
Previous Article:PAYGENT Launches Escrow Service for Mobile Auction Websites.
Next Article:Tohoku University Unveils the Effect of Light Environment on the Brains of Premature Infants.


Related Articles
Hitachi Demonstrates 3Gbit/s SAS Data Transfer Using Fully Integrated Hard Disk Controller.
The challenges of testing SATA and SAS: part 3: testing wide SAS.
PMC-Sierra announces SAS expander family for server storage applications.
SAS/SATA plugfest.
Smooth sailing for SAS? Not all technologies are created equal.
Teijin Pharma Launches New Compact CPAP Device for Sleep Apnea Syndrome Treatment.
Teijin Pharma Brings Tyco's CPAP Device GoodKnight 420 to Japan.
Teijin Pharma Introduces Compact CPAP Device.
Teijin Pharma, Sato Pharmaceutical Jointly Introduce Antipsoriatic Agent Bonalfa.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |